Influenza Vaccination in Patients With Multiple Sclerosis

William A. Sibley, Colin R. Bamford, Jose F. Laguna

Research output: Contribution to journalArticlepeer-review

31 Scopus citations


Vaccination was well tolerated by 93 patients with multiple sclerosis who received a total of 209 doses of influenza vaccine. In one patient, evidence of a new lesion developed after vaccination; the relapse rate was less than would be expected in the natural course of the illness. Toxic and allergic reactions appeared with 7% and 0.5% of the vaccinations, respectively—a rate no higher than that observed in the general population.

Original languageEnglish (US)
Pages (from-to)1965-1966
Number of pages2
JournalJAMA: The Journal of the American Medical Association
Issue number17
StatePublished - Oct 25 1976

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Influenza Vaccination in Patients With Multiple Sclerosis'. Together they form a unique fingerprint.

Cite this